Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

0.9667
-0.0149-1.52%
Post-market: 0.9650-0.0017-0.18%19:34 EDT
Volume:288.31K
Turnover:290.67K
Market Cap:1.44M
PE:-0.01
High:1.06
Open:0.9998
Low:0.9500
Close:0.9816
52wk High:524.00
52wk Low:0.9199
Shares:1.49M
Float Shares:1.48M
Volume Ratio:0.08
T/O Rate:19.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-175.9200
EPS(LYR):-303.4772
ROE:-106.98%
ROA:-53.08%
PB:0.11
PE(LYR):0.00

Loading ...

Clearmind Medicine Completes Dosing for Part a of Its of FDA-Regulated Phase I/Ii Clinical Trial

THOMSON REUTERS
·
Jun 16

Clearmind Medicine says HRT Financial files initial beneficial ownership statement

Reuters
·
Jun 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM

Reuters
·
Jun 08

Clearmind Medicine spotlights new CMND-100 alcohol use disorder trial data in June 10 webinar

Reuters
·
Jun 05

Clearmind Medicine to Feature New Insights From Cmnd-100 Psychedelic Clinical Trial on “Inside Meai” Webinar

THOMSON REUTERS
·
Jun 05

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

GlobeNewswire
·
Jun 05

Clearmind Medicine to sell $1.5 million in convertible promissory notes at 90% of face value

Reuters
·
Jun 02

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:27 AM

Reuters
·
Jun 01

Top Premarket Decliners

MT Newswires Live
·
Jun 01

Clearmind Medicine files Japanese patent application for 5-Methoxy-2-aminoindan

TIPRANKS
·
May 29

Clearmind Medicine files Japanese patent application for MEAI-based depression treatment

Reuters
·
May 29

Clearmind Medicine announces JHM-IRB approval to advance CMND-100 trial

TIPRANKS
·
May 26

Clearmind says Johns Hopkins IRB clears next stages of CMND-100 Phase I/II trial

Reuters
·
May 26

Clearmind Medicine Announces Johns Hopkins Irb Approval to Advance Cmnd-100 Phase I/Ii Clinical Trial to the Next Parts

THOMSON REUTERS
·
May 26

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM

Reuters
·
May 21

Clearmind Medicine Inc trading halted, news pending

TIPRANKS
·
May 21

Top Premarket Decliners

MT Newswires Live
·
May 19

Clearmind agrees to convert $600,000 notes into common shares at $0.3 each

Reuters
·
May 19

Clearmind Medicine announces 1-for-10 reverse share split

TIPRANKS
·
May 19

Clearmind Medicine to execute 1-for-10 reverse stock split May 21

Reuters
·
May 19